Saba Capital Management, L.P., a significant shareholder in abrdn Life Sciences Investors (NYSE:HQL), recently reported the sale of 62,743 shares of common stock, amounting to a total value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback